Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting

Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease

(2017) Han-Chang Huang et al.   JOURNAL OF ALZHEIMERS DISEASE

Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats

(2016) Ying-Zheng Zhao et al.   PLoS One

Intranasal Drug Delivery: How, Why and What for?

(2016) Anaísa Pires et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery

(2015) Maha Nasr   DRUG DELIVERY

Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid

(2015) Rajshree L. Shinde et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment

(2013) Sumeet Sood et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

(2013) David Olivares et al.   Current Alzheimer Research

A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke

(2013) Niyaz Ahmad et al.   PROTOPLASMA

Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease

(2012) Serge Gauthier et al.   Alzheimers & Dementia

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic

(2012) Anu Puri et al.   CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

Poly(ethylene glycol) Hydroxystearate-Based Nanosized Emulsions: Effect of Surfactant Concentration on Their Formation and Ability to Solubilize Quercetin

(2012) Cristiana L. Dora et al.   Journal of Biomedical Nanotechnology

Formulation and evaluation of microemulsion-basedin situion-sensitive gelling systems for intranasal administration of curcumin

(2012) Shuang Wang et al.   JOURNAL OF DRUG TARGETING

Protective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage

(2012) Han-Chang Huang et al.   NEUROCHEMICAL RESEARCH

A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis

(2012) Binu Chandran et al.   PHYTOTHERAPY RESEARCH

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

(2012) John M Ringman et al.   Alzheimers Research & Therapy

REVIEW: Curcumin and Alzheimer's Disease

(2010) Tsuyoshi Hamaguchi et al.   CNS Neuroscience & Therapeutics

Nano-interventions for neurodegenerative disorders

(2010) Clara Fernandes et al.   PHARMACOLOGICAL RESEARCH

Lipid nanocapsules: A new platform for nanomedicine

(2009) N.T. Huynh et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Activity of water-soluble turmeric extract using hydrophilic excipients

(2009) Suhit Gilda et al.   LWT-FOOD SCIENCE AND TECHNOLOGY

Curcumin: From ancient medicine to current clinical trials

(2008) H. Hatcher et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

(2008) Mukesh Kumar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease

(2008) Touqeer Ahmed et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR